154 related articles for article (PubMed ID: 21965727)
1. Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.
Du P; Ye L; Ruge F; Yang Y; Jiang WG
Anticancer Res; 2011 Oct; 31(10):3205-12. PubMed ID: 21965727
[TBL] [Abstract][Full Text] [Related]
2. The tumour suppressive role of metastasis suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway.
Du P; Ye L; Li H; Yang Y; Jiang WG
J Exp Ther Oncol; 2012; 10(2):91-9. PubMed ID: 23350348
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells.
Du P; Ye L; Li H; Ruge F; Yang Y; Jiang WG
Int J Mol Med; 2012 Mar; 29(3):428-34. PubMed ID: 22159313
[TBL] [Abstract][Full Text] [Related]
4. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
Parr C; Jiang WG
Eur J Cancer; 2009 Jun; 45(9):1673-83. PubMed ID: 19328678
[TBL] [Abstract][Full Text] [Related]
5. Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.
Zhang N; Ye L; Wu L; Deng X; Yang Y; Jiang WG
Anticancer Res; 2013 May; 33(5):1917-25. PubMed ID: 23645739
[TBL] [Abstract][Full Text] [Related]
6. Claudin-11 decreases the invasiveness of bladder cancer cells.
Awsare NS; Martin TA; Haynes MD; Matthews PN; Jiang WG
Oncol Rep; 2011 Jun; 25(6):1503-9. PubMed ID: 21468549
[TBL] [Abstract][Full Text] [Related]
7. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro.
Zhang N; Sanders AJ; Ye L; Kynaston HG; Jiang WG
Anticancer Res; 2010 Jan; 30(1):87-95. PubMed ID: 20150621
[TBL] [Abstract][Full Text] [Related]
9. Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis.
Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
Int J Oncol; 2015 Oct; 47(4):1429-39. PubMed ID: 26316204
[TBL] [Abstract][Full Text] [Related]
10. The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance.
Xie F; Ye L; Chen J; Wu N; Zhang Z; Yang Y; Zhang L; Jiang WG
J Transl Med; 2011 Jun; 9():95. PubMed ID: 21696600
[TBL] [Abstract][Full Text] [Related]
11. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D
Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152
[TBL] [Abstract][Full Text] [Related]
12. Loss of expression of growth differentiation factor-9 (GDF9) in human kidney cancer and regulation of growth and migration of kidney cancer cells by GDF9.
Du P; Ye L; Li H; Ruge F; Yang Y; Jiang WG
Anticancer Res; 2012 Oct; 32(10):4375-83. PubMed ID: 23060562
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of missing in metastasis gene (MIM) is associated with the progression of bladder transitional carcinomas.
Wang Y; Liu J; Smith E; Zhou K; Liao J; Yang GY; Tan M; Zhan X
Cancer Invest; 2007 Mar; 25(2):79-86. PubMed ID: 17453818
[TBL] [Abstract][Full Text] [Related]
14. The role of actinin-4 in bladder cancer invasion.
Koizumi T; Nakatsuji H; Fukawa T; Avirmed S; Fukumori T; Takahashi M; Kanayama H
Urology; 2010 Feb; 75(2):357-64. PubMed ID: 19969329
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation.
Sun Y; Cheng MK; Griffiths TR; Mellon JK; Kai B; Kriajevska M; Manson MM
Curr Cancer Drug Targets; 2013 Jan; 13(1):57-68. PubMed ID: 22920439
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines.
Nixdorf S; Grimm MO; Loberg R; Marreiros A; Russell PJ; Pienta KJ; Jackson P
Cancer Lett; 2004 Nov; 215(2):209-20. PubMed ID: 15488640
[TBL] [Abstract][Full Text] [Related]
18. LRIG1, a candidate tumour-suppressor gene in human bladder cancer cell line BIU87.
Yang WM; Yan ZJ; Ye ZQ; Guo DS
BJU Int; 2006 Oct; 98(4):898-902. PubMed ID: 16978290
[TBL] [Abstract][Full Text] [Related]
19. Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion.
Davies G; Jiang WG; Mason MD
Anticancer Res; 1999; 19(1A):547-52. PubMed ID: 10226596
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
